168 related articles for article (PubMed ID: 21102414)
1. Downregulation of ASPP1 in gestational trophoblastic disease: correlation with hypermethylation, apoptotic activity and clinical outcome.
Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN
Mod Pathol; 2011 Apr; 24(4):522-32. PubMed ID: 21102414
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome.
Siu MK; Wong ES; Chan HY; Ngan HY; Chan KY; Cheung AN
Am J Pathol; 2008 Oct; 173(4):1165-72. PubMed ID: 18772339
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of ASPP2 in choriocarcinoma contributes to increased migratory potential through Src signaling pathway activation.
Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN
Carcinogenesis; 2013 Sep; 34(9):2170-7. PubMed ID: 23671128
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts.
Kim YT; Cho NH; Ko JH; Yang WI; Kim JW; Choi EK; Lee SH
Cancer; 2000 Aug; 89(3):673-9. PubMed ID: 10931468
[TBL] [Abstract][Full Text] [Related]
5. DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases.
Fulop V; Colitti CV; Genest D; Berkowitz RS; Yiu GK; Ng SW; Szepesi J; Mok SC
Oncogene; 1998 Jul; 17(4):419-24. PubMed ID: 9696034
[TBL] [Abstract][Full Text] [Related]
6. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma.
Xue WC; Chan KY; Feng HC; Chiu PM; Ngan HY; Tsao SW; Cheung AN
J Mol Diagn; 2004 Nov; 6(4):326-34. PubMed ID: 15507671
[TBL] [Abstract][Full Text] [Related]
8. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
9. FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K/Akt Signaling.
Mak VC; Wong OG; Siu MK; Wong ES; Ng WY; Wong RW; Chan KK; Ngan HY; Cheung AN
Am J Pathol; 2015 Jul; 185(7):2038-48. PubMed ID: 26093985
[TBL] [Abstract][Full Text] [Related]
10. miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells.
Wang YX; Zhao JR; Xu YY; Wu WB; Zhang HJ
Int J Gynecol Cancer; 2017 Feb; 27(2):364-374. PubMed ID: 27922982
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27(kip1), and Ki-67 in normal placenta and gestational trophoblastic disease.
Olvera M; Harris S; Amezcua CA; McCourty A; Rezk S; Koo C; Felix JC; Brynes RK
Mod Pathol; 2001 Oct; 14(10):1036-42. PubMed ID: 11598175
[TBL] [Abstract][Full Text] [Related]
12. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases.
Xue WC; Feng HC; Tsao SW; Chan KY; Ngan HY; Chiu PM; Maccalman CD; Cheung AN
Int J Gynecol Cancer; 2003; 13(6):879-88. PubMed ID: 14675328
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
Persaud V; Ganjei P; Nadji M
West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression.
Wong SY; Ngan HY; Chan CC; Cheung AN
Mod Pathol; 1999 Nov; 12(11):1025-33. PubMed ID: 10574599
[TBL] [Abstract][Full Text] [Related]
15. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics.
Zhang HJ; Xue WC; Siu MK; Liao XY; Ngan HY; Cheung AN
Int J Gynecol Pathol; 2009 Mar; 28(2):172-8. PubMed ID: 19188816
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody.
Chiu PM; Ngan YS; Khoo US; Cheung AN
Histopathology; 2001 Mar; 38(3):243-9. PubMed ID: 11260306
[TBL] [Abstract][Full Text] [Related]
17. p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression.
Cheung AN; Shen DH; Khoo US; Wong LC; Ngan HY
J Clin Pathol; 1998 Feb; 51(2):159-62. PubMed ID: 9602692
[TBL] [Abstract][Full Text] [Related]
18. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
19. Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.
Candelier JJ; Frappart L; Yadaden T; Poaty H; Picard JY; Prévot S; Coullin P
Pathol Oncol Res; 2013 Apr; 19(2):217-27. PubMed ID: 23065465
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of SOX2 gene in hydatidiform mole and choriocarcinoma.
Li AS; Siu MK; Zhang H; Wong ES; Chan KY; Ngan HY; Cheung AN
Reprod Sci; 2008 Sep; 15(7):735-44. PubMed ID: 18836133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]